drugset / Trial / NCT06943534
Omalizumab Weight-Based Dosing Efficacy Trial
RandomizedParallel-groupSingle-blindTreatment
Summary
This research is being conducted to assess the safety and effectiveness of increased dosing of Omalizumab for food allergies.
Timeline
- Start
- 2025-07-03
- Primary completion
- 2027-05-01
- Completion
- 2028-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omalizumab | Monoclonal antibody | 5 mg/kg | — |
| Comparator | Omalizumab | Monoclonal antibody | 15 mg/kg | — |